期刊文献+

RP-HPLC法测定单硝酸异山梨酯鼻腔喷雾剂的含量和有关物质 被引量:1

Content Determination of Related Substances of Isosorbide Mononitrate Nasal Sprays by RP-HPLC
原文传递
导出
摘要 目的:建立测定单硝酸异山梨酯鼻腔喷雾剂含量及有关物质的方法。方法:采用反相高效液相色谱法。色谱柱为Di-amonsil C18柱,流动相为甲醇-水(30∶70),流速为1.0mL·min-1,检测波长为210nm,进样量为20μL;峰面积定量采用外标法。结果:单硝酸异山梨酯回归方程为Y=7892.7X+2980.7(r=0.9999),检测浓度在5~150μg·mL-1范围内与峰面积积分值线性关系良好;最低检出浓度为20ng·mL-1;高、中、低浓度日内、日间精密度的RSD在0.31%~0.93%之间;重复性试验RSD=0.69%(n=9);样品的平均回收率为101.02%(RSD=1.12%,n=9)。结论:该法准确、可靠、重复性好,可用于单硝酸异山梨酯鼻腔喷雾剂的含量及有关物质的测定。 To establish the method for the content determination of Isosorbide mononitrate nasal sprays and its related substances. METHODS: RP-HPLC method was adopted. The chromatographic column was Diamonsil C18 column. The mobile phase consisted of methanol-water (30:70) at flow rate of 1.0μg·mL^-1. The detection wavelength was set at 210 nm. The in- jection volurrm was 20 μL, and the external standard was adopted. RESULTS: The linear regression equation was Y=7 892.7X+ 2 980.7 (r=0.999 9), and the linear range of isosorbide mononitrate was 5-150 μg·mL^-1. The lowest detection limit was 20 ng·mL^-1. The RSD of intra-day and inter-day under low, medium and high concentrations were 0.31%-0.93%. The RSD of repeatability test was 0.69% (n=9). The average recoveries of samples was 101.02% (RSD=1.12%, n=9). CONCLUSION: The method is accurate, reliable and good reproducible. It is very suitable for the content determination of Isosorbide mononitrate nasal sprays and its related substances.
作者 庞武耀 刘文
出处 《中国药房》 CAS CSCD 北大核心 2011年第12期1132-1134,共3页 China Pharmacy
关键词 单硝酸异山梨酯 鼻腔喷雾剂 反相高效液相色谱法 Isosorbide mononitrate Nasal sprays RP-HPLC
  • 相关文献

参考文献4

  • 1Hutt V, Bonn R, Fritschi E, et al. Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers[J]. Arzneim-Forsch, 1995,45(2) : 142.
  • 2Kramer WG. Absorption of isosorbide-5-mononhrate at specific sites in the gastrointestinal tract[J]. J Clin Pharmacol, 1994,34(12) :1 218.
  • 3Niopas I, Daftsios AC, Nikolaidis N. Relative bioavailability of two isosorbide dinitrate sublingual tablet formulations administered as single doses in healthy subjects[J]. lnt .1 Clin Pharmacol Ther , 2001,39 (5) : 224.
  • 4国家食品药品监督管理局.化学药物杂质研究的技术指导原则[S].2005:17-28.

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部